Skip to content

Twist Bioscience Corporation

TWST

CIK 0001581280

← back to feed
Revenue (TTM)
$403.26M
+20.3% YoY Q2 Apr 2026
Net Income (TTM)
−$93.47M
+62.8% YoY Q2 Apr 2026
EPS Diluted (TTM)
−$1.54
+63.9% YoY Q2 Apr 2026
Gross Margin
51.7%
Q2 Apr 2026
Operating Margin
-37.3%
Q2 Apr 2026
Net Margin
-23.2%
Q2 Apr 2026
Free Cash Flow (TTM)
−$148.86M
Q2 Apr 2026
Cash
$122.67M
Q2 Apr 2026
Total Debt
$625K
Q2 Apr 2026
Shares Outstanding
62.27M sh
Q2 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings